Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04514991 · ClinicalTrials.gov registry record · NA

Bone Regenerative Techniques in Endodontic Microsurgery

A NA study of Apical Periodontitis, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT04514991: Completed NA study of Apical Periodontitis, sponsored by University of Pennsylvania.

NCT04514991 is a NA study of Apical Periodontitis that has completed, run by University of Pennsylvania. The registered enrollment target is 67 participants, roughly in line with the 62-participant average among 4 other Apical Periodontitis trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04514991, a NA study of Apical Periodontitis, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled clinical trial was to evaluate two dimensionally and 3-dimensionally the effect of resorbable collagen-based bone filling material on periapical healing following endodontic microsurgery (EMS) on endodontic lesions presenting four-wall defect.

Primary Outcome

Periapical healing was assessed by qualitatively evaluating bone regeneration through PA radiographs using well-established criteria. Molven's criteria categorize healing using periapical films into four categories: complete healing, incomplete healing, uncertain and unsatisfactory healing.

Conditions Studied

Interventions

  • DEVICE Foundation

Study Locations (1)

Pennsylvania

  • UPenn - Philadelphia

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2019-09-03
Est. Completion 2022-03-30
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT04514991 record still lists

NCT04514991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, roughly in line with the 62-participant average among 4 other Apical Periodontitis trials with a reported enrollment target.

The record links to 1 condition, with Apical Periodontitis appearing as the primary indexed condition, and to 1 intervention - of which Foundation is the first listed.

NCT04514991 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04514991 about?

NCT04514991 is a clinical study titled "Bone Regenerative Techniques in Endodontic Microsurgery". The purpose of this randomized controlled clinical trial was to evaluate two dimensionally and 3-dimensionally the effect of resorbable collagen-based bone filling material on periapical healing following endodontic microsurgery (EMS) on endodontic lesions presenting four-wall defect.

What is the current status of trial NCT04514991?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2019-09-03. Estimated completion is 2022-03-30.

What conditions does trial NCT04514991 study?

This clinical trial studies the following conditions: Apical Periodontitis.

What interventions are being tested in trial NCT04514991?

The interventions under investigation include: Foundation (DEVICE).

Who is sponsoring clinical trial NCT04514991?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04514991 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Apical Periodontitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04514991, the US trial registry maintained by the National Library of Medicine. NCT04514991 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.